Medtronic MiniMed has issued a Class II recall of its CareLink Clinic diabetes therapy management software due to incorrect data display. The recall, initiated Oct. 21, affects software version 4.2B, ...

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase ...

The pandemic didn't just disrupt global supply chains — it exposed a fundamental truth about the medical device industry: fragmented, reactive supply chain management is no longer viable in an era of ...

From left to right: Katie Adams, assistant editor at MedCity News; and Jennifer Thompson, vice president of U.S. aortic sales at Medtronic The process of commercializing a new medical device is ...

Forbes contributors publish independent expert analyses and insights. Ryan Finley writes about transfer pricing and international tax. In no case is the IRS’s favored method, the comparable profits ...

Medtronic beat on sales and earnings this morning. Management also upped its guidance for fiscal 2026 earnings. Sales and earnings are both growing by only single digits, and the stock costs 25 times ...

Medtronic MDT-0.25%decrease; red down pointing triangle is making changes to its board after Elliott Investment Management became one of its largest shareholders. The activist investor and the medical ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min As Medtronic prepares to spin ...

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026 and be immediately accretive to its EPS, operating, and gross margins. The spin-off will enable the ...

On Wednesday, the Centers for Medicare & Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ...

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. The new company will share a name with its flagship insulin pump, MiniMed.

Medtronic is increasing in-office work requirements to at least four days per week for employees in the United States who still work some days from home, an internal email from the Medtronic Executive ...